$Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment$

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment

Regorafenib (Stivarga, BAY 73-4506; Bayer Pharma AG, Berlin, Germany) is a novel oral multikinase inhibitor that blocks the activity of several protein kinases. However, few guidelines exist for novel biomarkers to select patients who will likely benefit from regorafenib treatment. Metastatic colore...

Full description

Bibliographic Details
Main Authors:	Min-Sang Lee, Hee Jin Cho, Jung Yong Hong, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seung Tae Kim
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835920965842

Similar Items

Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial
by: Seung Tae Kim, et al.
Published: (2019-04-01)

The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
by: Su Jin Lee, et al.
Published: (2018-04-01)

Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
by: Seung Tae Kim, et al.
Published: (2018-11-01)

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
by: Seung Tae Kim, et al.
Published: (2020-06-01)

Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.
by: Yoojoo Lim, et al.
Published: (2015-01-01)

gene amplification in patients with metastatic cancer
by: Su Jin Lee, et al.
Published: (2017-09-01)

Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system.
by: Jang Ho Cho, et al.
Published: (2019-01-01)

Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer
by: Jung Yong Hong, et al.
Published: (2021-08-01)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
by: Seung Tae Kim, et al.
Published: (2015-02-01)

Unique perception of clinical trials by Korean cancer patients
by: Lee Su Jin, et al.
Published: (2012-12-01)

Long-term regression after discontinuation of regorafenib administered for sorafenib-refractory hepatocellular carcinoma
by: Heewon Bae, et al.
Published: (2023-01-01)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
by: Selina K. Wong, et al.
Published: (2019-10-01)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
by: Jianyong Zhuo, et al.
Published: (2021-11-01)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
by: Jihoon Ko, et al.
Published: (2022-11-01)

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
by: Cheol-Hyung Lee, et al.
Published: (2020-07-01)

The effect of head posture on facial soft tissue changes captured by white-light facial scanning
by: Lim Jae-Beom, et al.
Published: (2019-01-01)

Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer
by: Youjin Kim, et al.
Published: (2017-12-01)

Serrated Polyposis Syndrome with a Synchronous Colon Adenocarcinoma Treated by an Endoscopic Mucosal Resection
by: Sang Hoon Lee, et al.
Published: (2020-09-01)

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
by: Donghao Xu, et al.
Published: (2022-03-01)

Prevalence of <i>RAF1</i> Aberrations in Metastatic Cancer Patients: Real-World Data
by: Sung Hee Lim, et al.
Published: (2023-12-01)

Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema
by: Jung-Jin Park, et al.
Published: (2023-04-01)

Prognostic significance of sealed-off perforation in colon cancer: a prospective cohort study
by: Kil-yong Lee, et al.
Published: (2018-12-01)

Successful resuscitation of refractory ventricular fibrillation with double sequence defibrillation
by: SungJoon Park, et al.
Published: (2021-02-01)

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer
by: Seung Tae Kim, et al.
Published: (2015-08-01)

LP-116 To get, or not to get: risk and benefit of COVID-19 vaccine in Korean patients with systemic lupus erythematosus
by: Young Ho Lee, et al.
Published: (2023-07-01)

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells
by: Hee Kyung Kim, et al.
Published: (2016-06-01)

Right colon perforation is associated with the higher mortality compared to left colon perforation
by: Kil-yong Lee, et al.
Published: (2021-07-01)

Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD
by: Kyung-Min Han, et al.
Published: (2020-07-01)

A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
by: Guan-Li Su, et al.
Published: (2020-07-01)

Outcomes according to treatment modalities as a bridge to curative surgery for malignant obstruction of the proximal colon: stent versus stoma
by: Yong Eun Park, et al.
Published: (2023-03-01)

Comparison of microbiota in the cloaca, colon, and magnum of layer chicken.
by: Seo-Jin Lee, et al.
Published: (2020-01-01)

Endoscopic Resection of Colonic Vascular Ectasia Mimicking as a Pedunculated Polypoid Lesion
by: Sang Hoon Lee, et al.
Published: (2019-06-01)

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma
by: Won‐Mook Choi, et al.
Published: (2020-07-01)

Comparison of Oncologic Outcomes Between Incomplete Obstructive Colon Cancer and Non-Obstructive Colon Cancer by Tumor Location
by: Ji Ha Lim, et al.
Published: (2022-06-01)

The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess: A Prospectively Enrolled Cross-sectional Study
by: Nae-Yun Heo, et al.
Published: (2016-10-01)

Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
by: Charny Park, et al.
Published: (2017-11-01)

Colonic Diffuse Large B-cell Lymphoma Hidden in Actinomycosis
by: Sang Hoon Lee, et al.
Published: (2019-07-01)

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
by: Jae Seung Lee, et al.
Published: (2020-01-01)

Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening
by: Sung Hee Lim, et al.
Published: (2019-11-01)

Effect of two different exercises on balance, pain and ankle motor function in male college students with chronic ankle instability
by: Young-Jun Park, et al.
Published: (2023-02-01)